After Alzheimer's drug shows promise, company to seek FDA approval
Wednesday, October 23, 2019
In a surprising reversal, U.S. drug company Biogen Inc. says it will seek approval for an Alzheimer's drug that had previously failed.
Copyright © 2024 by The Associated Press. All Rights Reserved.